Monitoring of Ceftolozane-Tazobactam Plasmatic Levels in Critical Patients

Monitoring of Ceftolozane-Tazobactam Plasmatic Levels in Critical Patients

The aim of this study is to determine the Ceftolozane-Tazobactam Plasmatic Levels and and analyse the clinical impact that might have the dose regimens that have been used until now.

Inclusion Criteria:

• Patients older than 18 years old.
• Hospitalised for a serious illness.
• Treated with Ceftolozane-Tazobactam
• Patients that signed the Informed Consent.

Exclusion Criteria:

• Allergic to any component of Ceftolozane-Tazobactam.
• Any surgical or medical evidence that according to the investigator could interfere with the pharmacodynamics of the medication: absorption, distribution, metabolism or excretion.
• Concomitant terminal illness.
• Unable to sign the Informed Consent.